Additional information
| Active substance | Fluoxetine |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Low risk, but liver function tests are recommended during prolonged use |
| Lab Test | Monitoring plasma levels is not routinely required but can be done if overdose is suspected or for pharmacokinetic studies |
| Strength | 60mg |
| Also known as | Prozac |
| Blood pressure | Typically has minimal effect on blood pressure |
| Trade name | Prozac, Sarafem, among others |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | (RS)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine |
| Formula | C17H18F3NO |
| Substance class | Selective Serotonin Reuptake Inhibitor (SSRI) |
| Main action | Inhibits the reuptake of serotonin in the brain |
| Half-life | 1 to 3 days for fluoxetine and 4 to 6 days for its active metabolite, norfluoxetine |
| Dosage (medical) | Typically 20 mg per day, may be adjusted based on response and tolerability |
| Dosage (sports) | Not applicable as it is not used to enhance athletic performance |
| Effects | Antidepressant, improves mood, sleep, appetite, and energy level |
| Side effects | Nausea, headache, dizziness, dry mouth, sweating, sleep disturbances, sexual dysfunction |
| Use in sports | None, as it does not enhance athletic performance |
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Packing | 10 caps/blister |
Fostimon (Merional) 75 (HMG) IBSA
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Prograf 5mg Astellas Pharma
DELETE - Micardis 80 mg Boehringer Ingelheim
FACTIVE 320 mg Abdi Ibragim
Zyban Glaxosmithkline
FUCIDIN 500 mg Abdi Ibragim
Fostimon (Merional) 150 IU HMG IBSA
Norvacs 10 mg Pfizer
Rovamycine 3.000.000 iu Eczacibasi
AVELOX 400 Bayer
NOLVA-20 INTEX PHARMA
NOLVABOLIC (TAMOXIFEN) Cooper Pharma
Plaquenil Sanofi
Prograf 1mg Astellas Pharma
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS 


Reviews
There are no reviews yet.